Nepal's Gandaki Province Passes Hemp Cultivation Bill for Medical Use
Provincial legislature advances framework for licensed industrial and medicinal hemp farming.

A scenic aerial view of terraced rice fields with farmers at work in Nepal, showcasing traditional agriculture.
Provincial Legislature Approves Hemp Framework
Gandaki Province became the first Nepali province to pass hemp-specific cultivation legislation, advancing a bill through its provincial assembly on August 15. The measure creates a licensing system for farmers and processors seeking to grow low-THC cannabis for fiber, seed oil, and medical extracts. Nepal's federal cannabis prohibition remains in place, but the 2015 constitution grants provinces authority over agricultural policy within their borders.
The bill doesn't specify a THC ceiling. That detail gets punted to forthcoming regulations from Gandaki's agriculture ministry. Provincial officials indicated the framework would align with international hemp standards—typically 0.3% delta-9 THC by dry weight—but no formal threshold has been published. Enforcement will fall to district agricultural offices, which will issue annual cultivation permits and conduct field inspections.
Medicinal and Industrial Use Cases Targeted
The legislation prioritizes two markets: industrial fiber for textiles and construction, and medicinal extracts for domestic pharmaceutical companies. Gandaki's mid-hill climate supports Cannabis sativa cultivation, and the province has historically grown wild hemp (locally called ganja or bhang) for rope and religious use. The new framework formalizes that cottage industry under a permitting regime.
Key provisions include:
- Mandatory seed certification from government-approved strains
- Prohibition on flower sales for recreational use
- Tracking requirements from seed to processor
- Export permits required for cross-border trade
The bill doesn't address THCA or delta-8 analogs—it focuses exclusively on total THC content in harvested material. That leaves open questions about decarboxylation during processing and whether post-harvest conversion would trigger compliance violations.
Federal Conflict and Enforcement Uncertainty
Nepal's 1976 Narcotic Drugs (Control) Act classifies all cannabis as a Schedule I narcotic, creating a direct conflict with Gandaki's provincial statute. Legal scholars expect the federal government to challenge the bill's constitutionality, though no formal objection has been filed as of August 15. Nepal's Supreme Court hasn't yet ruled on whether provincial agricultural authority supersedes federal drug scheduling.
If Kathmandu enforces the federal ban, Gandaki's permits become unenforceable—farmers would face prosecution under national law despite holding valid provincial licenses.
Two other provinces are drafting similar hemp bills. Koshi and Lumbini have both advanced preliminary language, according to provincial assembly records. If multiple provinces move forward, pressure on Nepal's federal parliament to harmonize drug policy will intensify. For now, Gandaki farmers are in legal limbo until the agriculture ministry publishes implementation rules and the federal government signals its enforcement posture.
For full background on this story, see the CannIntel topic hub on Nepal Hemp Legalization.
The next signal: whether Nepal's Ministry of Home Affairs files a constitutional challenge within the 30-day review window, and whether Gandaki's agriculture ministry sets a THC threshold that tracks international norms or carves out a higher limit for traditional medicinal use.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

DEA Rescheduling Objection Deadline Arrives Monday, August 18
Parties have until Monday to file formal objections to the DEA's proposed move of cannabis from Schedule I to Schedule III.

MMJ Federal Lawsuit Challenges DEA Rescheduling Timeline
Legal challenge filed in federal court could force DEA to restart administrative process, delaying Schedule III move past 2027.

Hawaii Officials Defend Hemp Crackdown in Court Filing
State argues unregulated hemp products pose public health risk in motion to dismiss industry challenge.
More from the newsroom

Virginia Hemp Restrictions Take Effect After Judge Declines to Block Law
A federal judge declined to issue a preliminary injunction against Virginia's new hemp regulations, allowing restrictions on intoxicating hemp products to take effect August 16, 2026.

American MSOs Eye Europe as U.S. Market Matures—Regulatory Gap Widens
Major U.S. cannabis operators are signaling European expansion plans, but fractured national frameworks and licensing bottlenecks threaten to stall cross-border capital.

Curaleaf Files to Acquire Aurora Cannabis for $272 Million
The all-stock deal marks the first cross-border MSO-LP merger since U.S. rescheduling proceedings began.